INOVIO PHARMACEUTICALS, INC. — Director's Dealing 2012

Nov 28, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: INOVIO PHARMACEUTICALS, INC. (INO)
CIK: 0001055726
Period of Report: 2012-11-26

Reporting Person: MARXE AUSTIN W & GREENHOUSE DAVID M (10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-11-26	Common Stock	S	300000	$0.4706	Disposed	5202206	Indirect
2012-11-27	Common Stock	S	650000	$0.4898	Disposed	4552206	Indirect

Footnotes

F1: This is a weighted average price.

F2: This is a joint filing by Austin W. Marxe (Marxe) and David M. Greenhouse (Greenhouse). They share voting and investment control over all securities owned by Special Situations Fund III QP, L.P. (SSFQP), Special Situations Cayman Fund, L.P. (Cayman), Special Situations Private Equity Fund, L.P. (PE) and Special Situations Life Sciences Fund, L.P. (LS). 2,526,827 shares of Common Stock are held by SSFQP, 802,640 shares of Common Stock are held by Cayman, 784,154 shares of Common Stock are held by PE and 438,585 shares of Common Stock are held by LS. The interest of Marxe and Greenhouse in the shares of Common Stock owned by SSFQP, Cayman, PE and LS is limited to the extent of his pecuniary interest.